Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
B2241 OndansetronTarget: 5-HT3 ReceptorsSummary: serotonin 5-HT3 receptor antagonist
-
B2252 Paroxetine HCl1 CitationTarget: 5-HT TransportersSummary: Antidepressant agents
-
B1572 LatrepirdineTarget: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptorSummary: Brain cell death inhibitor
-
B2248 KetanserinTarget: 5-HT2 ReceptorsSummary: specific 5-HT2A serotonin receptor antagonist
-
B1568 Azelastine HClTarget: Histamine H1 ReceptorsSummary: Potent, second-generation, selective, histamine receptor antagonist
-
B1616 Trospium chlorideTarget: AChRSummary: Antimuscarinic agent
-
B1610 Gallamine TriethiodideTarget: M2 ReceptorsSummary: Cholinergic receptor blocker
-
B1612 Pancuronium dibromideTarget: AChRSummary: AChR antagonist
-
B1482 Dopamine HClSummary: Dopamine D1-5 receptors agonist
-
A8369 Atropine sulfate monohydrateTarget: M3 Receptors|M1 Receptors|M2 Receptors|M4 Receptors|M5 ReceptorsSummary: MAChRs antagonist